US Nearing 350,000 Daily COVID-19 Vaccine Doses

January 5, 2021
Kevin Kunzmann

In the first week of 2021, the US is currently leading all countries in total vaccine administrations, despite state-level distribution setbacks.

As of Monday, the United States has administered more than 4.5 million doses of coronavirus 2019 (COVID-19) vaccine to its population, per estimated counts from the US Centers for Disease Control and Prevention (CDC) and University of Oxford.

While discussion surrounding the distribution of recently-authorized two-dose mRNA vaccines BNT162b2 from Pfizer and BioNTech, and mRNA-1273 from Moderna, has focused on the merits of single-dose versus standard administration, the nation has increased its daily vaccination count from approximately 235,000 to 348,000 in just one week.

Presently, the very small countries of Israel and Bahrain are reporting a substantial vaccination count per capita, while the United States improves on a slow rollout start.

United States4.56 million1.38 per 100
China4.5 million0.31 per 100
Israel1.22 million14.14 per 100
United Kingdom944,5391.39 per 100
Russia800,0000.55 per 100
Germany265,6100.32 per 100
Italy128,8800.21 per 100
Canada117,7680.31 per 100
Spain82,8340.18 per 100
Bahrain61,6123.62 per 100

Data per Our World in Data (Jan 5, 2021, 12 AM EST)

Unsurprisingly, among the most vaccinated states thus far are California, Texas, and New York—large, highly populated regions notably affected during various waves of the pandemic since March 2020.

California451,7021.14 per 100
Texas374,2381.29 per 100
New York274,7131.41 per 100
Florida264,5121.23 per 100
Colorado262,2751.95 per 100
Illinois176,5771.39 per 100
Pennsylvania163,2071.28 per 100
Ohio159,8691.37 per 100
Tennessee152,5162.23 per 100
Massachusetts110,2791.60 per 100

Data per CDC COVID-19 Tracker (Jan 4, 2021, 9 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

What More COVID-19 Testing Can Do for 2021

Moderna Vaccine Shows Significant COVID-19 Prevention Efficacy in Phase 3 Data

UK Approves Emergency Authorization for the AstraZeneca and Oxford COVID-19 Vaccine